HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $9 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Rockwell Medical (NASDAQ:RMTI) and maintained a price target of $9.
September 04, 2024 | 11:04 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Rockwell Medical, maintaining a price target of $9. This suggests confidence in the company's future performance and potential stock price appreciation.
The reiteration of a Buy rating and maintenance of a $9 price target by HC Wainwright & Co. indicates a positive outlook on Rockwell Medical's stock. This can lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100